National Cancer Institute; Amended Notice of Meeting, 46409 [2024-11728]

Download as PDF Federal Register / Vol. 89, No. 104 / Wednesday, May 29, 2024 / Notices and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Delegation of Authorities Notice is hereby given that I have delegated to the Deputy Secretary within the Office of the Secretary (OS)/ Immediate Office of the Secretary (IOS)/ Office of the Deputy Secretary the authority vested in me as the Secretary of Health and Human Services (HHS) pursuant to section 41 U.S.C. 4712(c)(1), to issue an order denying relief as a final agency action for cases in which the Office of the Inspector General (OIG)/ Office of Investigations has found allegations of whistleblower retaliation to be unsubstantiated. This delegation supersedes any and all delegations of authority within IOS or in any other U.S. Department of Health and Human Services Operating Division or Staff Division relating to denying relief as a final agency action for unsubstantiated whistleblower complaints as determined by OIG (pursuant to 41 U.S.C. 4712(c)(1)). I hereby affirm and ratify any actions taken by the Deputy Secretary of HHS, or other officials, which involve the exercise of these authorities prior to the effective date of this delegation. This delegation of authority is effective immediately. This delegation of authority may be re-delegated. This delegation of authority does not impact any other delegations of authority within any other Department of Health and Human Services Operating Division or Staff Division. Xavier Becerra, Secretary. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Closed Meeting lotter on DSK11XQN23PROD with NOTICES1 [FR Doc. 2024–11729 Filed 5–28–24; 8:45 am] Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, Jkt 262001 Group; Microbiology and Infectious Diseases B Research Study Section. Date: June 20–21, 2024. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20852 (Video Assisted Meeting). Contact Person: Mario Cerritelli, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC 9823, Rockville, MD 20892, 240–669–5199, cerritem@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: May 22, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–11696 Filed 5–28–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting BILLING CODE P 18:05 May 28, 2024 Dated: May 22, 2024. David W Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2024–11683 Filed 5–28–24; 8:45 am] VerDate Sep<11>2014 Name of Committee: Scientific & Technical Review Board on Biomedical & Behavioral Research Facilities, STOD to review grant applications. Date: June 24, 2024, to June 25, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Santanu Banerjee, Scientific Review Officer (SRO), Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, (RK2)/808–M, Bethesda, MD 20892, (301) 435–5947, santanu.banerjee@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) 46409 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, National Cancer Institute, July 8, 2024, 10:00 a.m. to July 9, 2024, 02:00 p.m., National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892 which was published in the Federal Register on May 13, 2024, FR Doc. No. 2024–10293, 89 FR 41445. This meeting notice is being amended to change the meeting type from closed to partially closed. On July 8, 2024, the open session will be held from 10:00 a.m. to 10:35 a.m. and the closed session will now be held from 10:35 a.m. to 1:45 p.m. On July 9, 2024, the closed session will now be held from 10:00 a.m. to 3:00 p.m. The meeting is partially closed to the public. Dated: May 22, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–11728 Filed 5–28–24; 8:45 am] BILLING CODE 4140–01–P Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review PO 00000 Frm 00052 Fmt 4703 Sfmt 9990 E:\FR\FM\29MYN1.SGM 29MYN1

Agencies

[Federal Register Volume 89, Number 104 (Wednesday, May 29, 2024)]
[Notices]
[Page 46409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11728]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Board of 
Scientific Counselors, National Cancer Institute, July 8, 2024, 10:00 
a.m. to July 9, 2024, 02:00 p.m., National Cancer Institute, 9609 
Medical Center Drive, Bethesda, MD 20892 which was published in the 
Federal Register on May 13, 2024, FR Doc. No. 2024-10293, 89 FR 41445.
    This meeting notice is being amended to change the meeting type 
from closed to partially closed. On July 8, 2024, the open session will 
be held from 10:00 a.m. to 10:35 a.m. and the closed session will now 
be held from 10:35 a.m. to 1:45 p.m. On July 9, 2024, the closed 
session will now be held from 10:00 a.m. to 3:00 p.m. The meeting is 
partially closed to the public.

    Dated: May 22, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-11728 Filed 5-28-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.